1-4 of 4
Michael Hemann
Close
Sort by
Journal Articles

Inherent Genome Instability Underlies Trisomy 21-Associated Myeloid Malignancies

Chun-Chin Chen, Angelika Amon, Michael Hemann, Robert Grant Rowe
Journal: Blood
Blood (2023) 142 (Supplement 1): 1388.
https://doi.org/10.1182/blood-2023-181931
Published: 2023
Journal Articles

Creatine Kinase Pathway Inhibition Alters GSK3 and WNT Signaling in EVI1-Positive Acute Myeloid Leukemia

Lina Benajiba, Gabriela Alexe, Olivier Hermine, MD PhD, Michael Hemann, Alexandre Puissant, Kimberly Stegmaier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1191.
https://doi.org/10.1182/blood.V130.Suppl_1.1191.1191
Published: 2017
Journal Articles

Exploiting an Asp-Glu "Switch" in Glycogen Synthase Kinase 3 to Design Paralog Selective Inhibitors for Acute Myeloid Leukemia Treatment

Lina Benajiba, Florence Wagner, PhD, Arthur Campbell, Michel Weiwer, Sacher Joshua, Jennifer Gale, Linda Ross, Alexandre Puissant, Gabriela Alexe, Amy Conway, Morgan Back, Yana Pikman, MD, Ilene Galinsky, Daniel J. DeAngelo, MD, Richard M. Stone, MD, Taner Kaya, Xi Shi, Matthew Robers, Thomas Machleidt, Olivier Hermine, MD PhD, Andrew L. Kung, MD PhD, Adam Stein, Michael Hemann, Edward Scolnick, Yan-Ling Zhang, Jen Pan, Edward Holson, Kimberly Stegmaier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2075.
https://doi.org/10.1182/blood.V130.Suppl_1.2075.2075
Published: 2017
Journal Articles

Vcp-Regulated Homologous Recombination Represents a New Druggable Vulnerability in Acute Myeloid Leukemia

Lina Benajiba, Nina Fenouille, Edyta Malolepsza, Jana M Ellegast, MD, Gabriela Alexe, Yana Pikman, MD, Frédéric Luciano, Ilene Galinsky, Daniel J. DeAngelo, MD, Richard M. Stone, MD, Patrick Auberger, PhD, Josee Guirouilh-Barbat, Bernard Lopez, Mehdi Khaled, Kasper Lage, Olivier Hermine, MD PhD, Michael Hemann, Alexandre Puissant, Kimberly Stegmaier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 880.
https://doi.org/10.1182/blood.V130.Suppl_1.880.880
Published: 2017